Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1938 of 5804
-
New brain zapping technique shows promise for depression
Symptom relief OngoingRepetitive Transcranial magnetic stimulation (TMS) uses magnetic fields to modulate brain activity. A novel form of repetitive TMS (rTMS), intermittent theta burst stimulation (iTBS), has emerged as a promising new treatment for depression. This technique may be advantageous due …
Phase: NA • Sponsor: The Royal Ottawa Mental Health Centre • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New study tests stepped care for alcohol problems in refugee communities
Disease control CompletedThis is a randomized controlled trial (RCT) evaluating the effectiveness of a screening, brief intervention, and referral to treatment (SBIRT) stepped-care system in reducing unhealthy AOD use among Congolese refugees and the host community in Mantapala, an integrated settlement …
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New scan method could prevent unnecessary stents after heart attacks
Knowledge-focused OngoingHeart attacks caused by the complete blockage of a heart artery are treated by opening it with a stent. However, most people will also have 'non-culprit' narrowings found in their other arteries at this time. Although in general people do better if these non-culprit narrowings a…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a Nurse-Led digital Check-In keep heart failure patients out of the hospital?
Disease control OngoingHeart failure (HF) is a leading cause of hospitalisation and disability-adjusted life years lost, with mortality rates exceeding most cancers. Despite compelling evidence and recommendations, less than 20% of the HF patients are followed-up by the specialist healthcare after hosp…
Phase: NA • Sponsor: Vestre Viken Hospital Trust • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
AI could spot lung complications before they happen
Knowledge-focused Recruiting nowPostoperative pulmonary complications (POPC) are common after general anaesthesia and are a major cause of increased morbidity and mortality in surgical patients. However, prevention and treatment methods for POPC that are considered effective, tie up human and technical resource…
Sponsor: Britta Trautwein • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a quick brain zap keep depression away?
Disease control Recruiting nowThis is a randomized, multi-center, open-label study in which patients with depression who responded to an open-label treatment with intermittent theta burst stimulation (iTBS) will receive this procedure as maintenance therapy. The patients will be randomized to two study arms. …
Phase: NA • Sponsor: Berthold Langguth, MD, Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New study aims to personalize chemo for HIV-Linked cancer
Knowledge-focused OngoingThis prospective, nonrandomized, open-label, single-arm, cohort study examines the effects of chemotherapy provided under local standard of care in patients with pathologically confirmed HIV-associated Kaposi Sarcoma (HIV-KS). Previous HIV-KS studies demonstrated significant vari…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New spectacle lens aims to halt myopia in teenagers
Disease control CompletedChina is a major country in myopia, with the highest number of teenagers suffering from myopia. Controlling the progression of myopia and the related complications caused by axial elongation have clinical significance and social value. Currently. There is a lack of researches on …
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Brain scans could reveal early warning signs of Parkinson's
Knowledge-focused Recruiting nowREM sleep behavior disorder is a parasomnia that reflects the presence of alpha-synucleinopathy in the brain and is highly predictive of eventual phenoconversion to Parkinson's disease, dementia with Lewy bodies, or multiple system atrophy over the course of years to decades. Neu…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can dance fitness keep your brain young? new study tests it in older african americans
Knowledge-focused Recruiting nowThe goal of this clinical trial is to test the effects of different types of exercise on brain health and Alzheimer's risk in older African Americans. Specifically, the main question\[s\] it aims to answer are: * What is the effect of a Cardio-Dance Fitness (CDF) vs. a Strength…
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Could a common ED drug boost chemo for stomach cancer?
Disease control OngoingThe goal of this clinical trial is to assess the ability of Tadalafil alone and in combination with neoadjuvant FLOT (5-Fluorouracil, Oxaliplatin, and Docetaxel) chemotherapy to suppress myeloid derived suppressor cells (MDSCs) in patients with resectable gastric or gastroesophag…
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Robot-Assisted lung biopsy shows promise in accuracy study
Diagnosis CompletedThe aim of this research study is to evaluate the effectiveness of the ION endoluminal system at reaching and obtaining biopsies from lung nodules when used in combination with 3-dimensional imaging such as CT scans. Data on safety will also be collected.
Phase: NA • Sponsor: Intuitive Surgical • Aim: Diagnosis
Last updated Jun 26, 2026 14:54 UTC
-
Can a phone app ease PTSD? large study puts it to the test.
Symptom relief CompletedThe investigators will complete an entirely remote randomized controlled trial (RCT) comparing 14 sessions of attention bias modification (ABM), attention control training (ACT), placebo neutral attention training, and a final control condition with daily questions in 1,897 indiv…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New tool helps doctors and patients tackle obesity in diabetes
Disease control OngoingDespite steady increases in obesity prevalence, the more than 12 million obese U.S. adults with type 2 diabetes (T2DM) and severe obesity encounter a number of barriers to adopting effective surgical and pharmaceutical treatments, including: (a) both patients and primary care cli…
Phase: NA • Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a Pre-Surgery sedative improve Kids' hospital experience?
Symptom relief Recruiting nowChildren undergoing general anesthesia for surgery commonly need sedative and anxiolytic premedication but little clinical evidence supports is benefit for children older than 7 years old. The aim of this prospective randomized clinical trial is to assess the impact of pharmacol…
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New combo for colorectal cancer shows promise but trial halted early
Disease control TerminatedThis is a randomized, open-label, dose/schedule optimization study comparing NUC-3373/leucovorin (LV)/irinotecan plus bevacizumab (NUFIRI-bev) to 5-FU/LV/irinotecan plus bevacizumab (FOLFIRI-bev) for the treatment of patients with unresectable metastatic colorectal cancer. A tot…
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jun 26, 2026 15:54 UTC
-
New TB vaccines enter human testing – could they prevent a global killer?
⭐️ VACCINE ⭐️ CompletedThis randomized, placebo-controlled, double-blind, safety and dose-finding Phase Ia trial will evaluate four dose levels of the BNT164 investigational vaccines (BNT164a1 and BNT164b1) to select a safe and tolerable dose in a three-dose schedule.
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC
-
Eye-Tracking tech could spot macular degeneration faster
Diagnosis OngoingThe study aims to evaluate the Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system in the ability to detect and assess central vision dysfunction in a personalized, adaptive, objective, and automated way through eye gaze tracking in age-relat…
Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New painkiller injection could ease recovery after hernia repair
Symptom relief CompletedSubjects receive either CPL-01, positive control, or negative control after herniorrhaphy and are then followed.
Phase: PHASE3 • Sponsor: Cali Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Can a simple text message help young people with HIV stay on track?
Disease control CompletedThis research study uses a cluster randomized controlled trial design to evaluate the effectiveness of Treatment Text (TXTXT) intervention on adherence and viral load suppression at 3- and 6- months post intervention initiation for youth and young adults with HIV. A total of 12 c…
Phase: NA • Sponsor: Amy K. Johnson, PhD, MSW • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC